Richard W. Paul & Associates’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8
Closed -$119 463
2024
Q4
$119 Hold
8
﹤0.01% 503
2024
Q3
$153 Hold
8
﹤0.01% 493
2024
Q2
$166 Hold
8
﹤0.01% 484
2024
Q1
$150 Hold
8
﹤0.01% 496
2023
Q4
$115 Hold
8
﹤0.01% 487
2023
Q3
$139 Hold
8
﹤0.01% 493
2023
Q2
$166 Hold
8
﹤0.01% 519
2023
Q1
$188 Sell
8
-4
-33% -$107 ﹤0.01% 530
2022
Q4
$341 Buy
+12
New +$307 ﹤0.01% 506

Other funds holding OGN

Richard W. Paul & Associates's OGN Position: Q1 2025 in Review

Richard W. Paul & Associates sold out of Organon & Co (OGN) in Q1 2025, closing a stake of 8 shares — an estimated $119 sold.

Richard W. Paul & Associates first reported a position in OGN in Q4 2022 and held it in 9 quarters. The position peaked at $341 in Q4 2022. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2025.

  • Richard W. Paul & Associates reported no remaining Organon & Co position as of Q1 2025 after selling out during the quarter.
  • Richard W. Paul & Associates sold 8 Organon & Co shares in Q1 2025, an estimated $119.
  • Richard W. Paul & Associates first reported a position in Organon & Co in Q4 2022 and held it in 9 quarters.
  • Richard W. Paul & Associates's Organon & Co position peaked at $341 in Q4 2022.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2025.

Based on Richard W. Paul & Associates's 13F filing for Q1 2025, filed 12 May 2025.